Cardinal Health extends CVS deal through 2032 as Cardinal Health stock costs EUR 222.75
Published on 10/24/2026 at 10:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAgreement and trading dates
- Cardinal Health announced the CVS agreement extension on October 1, 2026, through June 30, 2032.
- Cardinal Health stock trades in weekend trading at Lang & Schwarz at EUR 222.75 at 10:48 a.m. CEST on October 24, 2026.
- The next Xetra session is scheduled for October 26, 2026.
Cardinal Health announced on October 1, 2026, that it had entered into a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032, while Cardinal Health stock costs EUR 222.75 in weekend trading. The announcement and the guidance reaffirmation were published by Cardinal Health.
Market context: Market report S&P 500.
Weekend trading
Lang & Schwarz showed Cardinal Health at EUR 222.75 at 10:48 a.m. CEST on October 24, 2026. The bid was EUR 222.30 and the ask was EUR 223.20. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Cardinal Health stock.
CVS agreement
The letter of intent preserves Cardinal Health’s current scope of distribution services for CVS Health. In connection with the renewal, Cardinal Health reaffirmed fiscal 2027 non-GAAP earnings-per-share guidance of USD 12.40 to USD 12.60, representing growth of 13 percent to 15 percent. The company also reaffirmed its long-term non-GAAP earnings-per-share growth guidance of 12 percent to 14 percent, according to the company release.
Next Xetra session
The next Xetra session is scheduled for October 26, 2026. Cardinal Health said its first-quarter fiscal 2027 results are planned for release on November 5, 2026, before trading begins on the New York Stock Exchange, according to a separate company announcement.
